2. Academic Validation
  3. Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion

Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion

  • Peptides. 2019 Feb;112:14-22. doi: 10.1016/j.peptides.2018.10.004.
Jun Xu 1,  Shuo Chen 2,  Jing Jin 3,  Lingman Ma 4,  Min Guo 5,  Changlin Zhou 6,  Jie Dou 7
Affiliations

Affiliations

  • 1 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 675454514@qq.com.
  • 2 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 1220018125@qq.com.
  • 3 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 435241872@qq.com.
  • 4 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: malingman1987@126.com.
  • 5 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: 1020152471@cpu.edu.cn.
  • 6 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: cl_zhou@cpu.edu.cn.
  • 7 School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Electronic address: doujie@cpu.edu.cn.
PMID: 30447229 DOI: 10.1016/j.peptides.2018.10.004
Abstract

Influenza A virus is a leading cause of mortality in humans and poses a global health emergency due to its newly adapted and resistant strains. Thus, there is an urgency to develop novel anti-influenza drugs. Peptides are a type of biological molecule having a wide range of inhibitory effects against bacteria, fungi, viruses and Cancer cells. The prospects of several Peptides and their mechanisms of action have received significant attention. BF-30, a 30 amino acid residue peptide isolated from the venom of the snake, Bungarus fasciatus, is reported to have Antibacterial and antitumor activities. Here, we demonstrated that the 50% cytotoxic concentration (CC50) of the peptide to MDCK cells is 67.7 μM. While BF-30 could inhibit the Influenza Virus strains H1N1, H3N2 and the oseltamivir-resistant strain H1N1, in vitro, with 50% effective concentration (EC50) of 5.2, 7.4 and 18.9 μM, respectively. In animal experiments, mice treated with BF-30 showed 50% survival at a dosage of 4 μM, with an approximately 2 log viral titer decrease in the lung. However, further studies showed that BF-30 worked on only the virus invasion stage, and inhibited the Influenza Virus infection by causing virion membrane fusion rather than interacting with hemagglutinin or neuraminidase. These results demonstrated that the peptide BF-30 exhibited an effective inhibitory activity against the influenza A virus and could be a promising candidate for Influenza Virus therapy.

Keywords

Antiviral activity; Influenza A virus; Oseltamivir-resistant; Peptide BF-30; Virion membrane fusion.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z